We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$121B
AUM Growth
+$9.79B
Cap. Flow
-$942M
Cap. Flow %
-0.78%
Top 10 Hldgs %
9.24%
Holding
5,958
New
1,032
Increased
1,969
Reduced
1,595
Closed
616

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$986M
2
SE icon
Sea Limited
SE
+$480M
3
SNOW icon
Snowflake
SNOW
+$441M
4
C icon
Citigroup
C
+$422M
5
ORCL icon
Oracle
ORCL
+$393M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$575M
2
AAPL icon
Apple
AAPL
+$515M
3
MA icon
Mastercard
MA
+$506M
4
DIS icon
Walt Disney
DIS
+$447M
5
BABA icon
Alibaba
BABA
+$434M

Sector Composition

Rank Sector Weight
1 Technology 13.97%
2 Consumer Discretionary 9.19%
3 Financials 7.48%
4 Healthcare 7.05%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OESX icon
4801
Orion Energy Systems
OESX
$85.8M
$156K ﹤0.01%
4,309
+3,112
+260% +$120K
GLAD icon
4802
Gladstone Capital
GLAD
$448M
$155K ﹤0.01%
6,688
-45
-0.7% -$1.04K
ROOT icon
4803
CALL
Root
ROOT
$876M
$155K ﹤0.01%
+2,778
New +$217K
OPAD icon
4804
Offerpad Solutions
OPAD
$20.7M
$154K ﹤0.01%
160
-202
-56% -$232K
DMAQR
4805
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
$154K ﹤0.01%
+480,000
New +$152K
ATNM icon
4806
Actinium Pharmaceuticals
ATNM
$32.9M
$153K ﹤0.01%
25,473
-2,646
-9% -$19.9K
JAKK icon
4807
Jakks Pacific
JAKK
$292M
$153K ﹤0.01%
15,062
-12,187
-45% -$136K
MBAC.WS
4808
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$153K ﹤0.01%
131,498
RPT
4809
Rithm Property Trust
RPT
$102M
$152K ﹤0.01%
1,926
-1,240
-39% -$101K
BNGO icon
4810
Bionano Genomics
BNGO
$14.4M
$151K ﹤0.01%
+84
New +$225K
TMAC.WS
4811
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$151K ﹤0.01%
269,562
ASUR icon
4812
Asure Software
ASUR
$251M
$150K ﹤0.01%
19,192
+4,340
+29% +$37.9K
LITS
4813
Lite Strategy Inc
LITS
$35M
$150K ﹤0.01%
+2,810
New +$157K
XOS icon
4814
Xos
XOS
$49.6M
$150K ﹤0.01%
1,585
-31,748
-95% -$3.92M
EIGR
4815
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$150K ﹤0.01%
+966
New +$187K
GOL
4816
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$150K ﹤0.01%
24,800
JMACW
4817
DELISTED
Maxpro Capital Acquisition Corp. Warrants
JMACW
$150K ﹤0.01%
+375,000
New +$151K
AYTU icon
4818
AYTU BioPharma
AYTU
$24.8M
$148K ﹤0.01%
5,482
-4,186
-43% -$181K
BTTX
4819
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$148K ﹤0.01%
+31,848
New +$261K
APGB.WS
4820
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$148K ﹤0.01%
156,051
MSDAW
4821
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$147K ﹤0.01%
128,230
-11,770
-8% -$14.6K
GLRE icon
4822
Greenlight Captial
GLRE
$507M
$146K ﹤0.01%
18,569
-32,712
-64% -$240K
AONCW
4823
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$146K ﹤0.01%
220,646
ALDX icon
4824
Aldeyra Therapeutics
ALDX
$91.7M
$145K ﹤0.01%
36,228
+21,947
+154% +$167K
KNSA icon
4825
Kiniksa Pharmaceuticals
KNSA
$6.19B
$145K ﹤0.01%
+12,317
New +$151K

Similar funds

David Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, David Shaw held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw's Q4 2021 filing shows 1,032 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

  • David Shaw's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
  • David Shaw added most to Sea Limited in Q4 2021, an estimated $480M increase.
  • David Shaw's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
  • David Shaw fully exited Aon in Q4 2021, selling an estimated $179M.
  • David Shaw's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
  • David Shaw opened 1,032 new positions and closed 616 in Q4 2021.
  • David Shaw's portfolio value rose 8.8% quarter-over-quarter to $121B.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.